Abstract
The novel Coronavirus-19 disease (COVID-19) has emerged as a pandemic and has presented itself as an unprecedented challenge to the majority of countries worldwide. The containment measures for this disease such as the requirement of health care facilities greatly rely on estimating the future dynamics and flattening of the COVID-19 curve. However, it is always challenging to estimate the future trends and flattening of the COVID-19 curve due to the involvement of many real-life variables. Recently, traditional methods based on SIR and SEIR have been presented for predictive monitoring and detection of flattening of the COVID-19 curve. In this paper, a novel method for detection of flattening of the COVID-19 curve and its ending life-cycle using only the time-series of new cases per day is presented. Simulation results are compared to the SIR based methods in three different scenarios using COVID-19 curves for South Korea, the United States of America, and India. In this study, simulations, performed on the 26th April 2020 show that the peak of the COVID-19 curve in the USA has already arrived and situated on the 14th of April 2020, while the peak of the COVID-19 curve for India has yet to arrive.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This is not a clinical trial
Funding Statement
No funding has been received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data has been obtained from our world in data website